Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01929824 · ClinicalTrials.gov registry record
Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 50
- Enrollment target
NCT01929824: Completed study, sponsored by Mayo Clinic.
NCT01929824 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01929824 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study is aimed at understanding whether oral nitric oxide levels can be used as a non-invasive marker for the diagnosis and management of patient with eosinophilic esophagitis (EoE).
Primary Outcome
To determine if oral NO correlates to activity of disease in EoE
Interventions
- OTHER Oral Nitric Oxide testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-08 |
| Est. Completion | 2019-09-25 |
What the finished NCT01929824 record still lists
NCT01929824 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Oral Nitric Oxide testing is the first listed.
NCT01929824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01929824 about?
NCT01929824 is a clinical study titled "Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)". This study is aimed at understanding whether oral nitric oxide levels can be used as a non-invasive marker for the diagnosis and management of patient with eosinophilic esophagitis (EoE).
What is the current status of trial NCT01929824?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-08. Estimated completion is 2019-09-25.
What interventions are being tested in trial NCT01929824?
The interventions under investigation include: Oral Nitric Oxide testing (OTHER).
Who is sponsoring clinical trial NCT01929824?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia